B-cell lymphoma is a type of blood cancer that affects the B lymphocytes of the immune system. They usually arise in the lymph nodes or in other lymphoid tissue, such as the spleen, bone marrow ...

is a nervous-system-seeking extranodal non-Hodgkin's lymphoma (NHL). Microscopically, PCNSL resembles systemic diffuse large B-cell lymphoma (DLBCL) and the two disorders share common molecular ...

Extranodal non-Hodgkin lymphoma (NHL) makes up over one-third of NHL cases, yet remains understudied and in need of deeper ...

NEW DELHI: India’s first global CAR T-cell therapy for adult B-cell Non-Hodgkin Lymphoma (B-NHL), a kind of blood cancer that affects the lymphatic system, has been launched in the country ...

Get Instant Summarized Text (Gist) A phase 1 clinical trial indicates that a new off-the-shelf immunotherapy using CAR-NK cells shows promise for treating B-cell lymphomas. This approach, derived ...

Ultrasensitive detection of circulating tumor DNA can improve clinical outcomes in aggressive B-cell lymphomas by identifying measurable residual disease. Defining remission is challenging due to ...

country’s first global CAR T-cell therapy for adult B-cell non-Hodgkin lymphoma (B-NHL). A personalized therapy for adult patients with relapsed or refractory B-NHL, the company which is India’s ...

If left untreated, patients with these rare and aggressive forms of non-Hodgkin’s lymphoma typically only ... affected by primary mediastinal B-cell lymphoma, for whom CAR-T cell therapy would ...

While the trial was not designed to evaluate efficacy, Ghobadi and colleagues said that responses were observed across B-cell lymphoma histologies among those treated with the combination ...

is grouped into two major types—Hodgkin’s and non-Hodgkin’s. Hodgkin’s lymphoma is a B-cell lymphoma. Non-Hodgkin’s lymphoma is further divided into over 60 subtypes. B-cell lymphomas ...

a CAR T-cell therapy for adult B-cell Non-Hodgkin Lymphoma (B-NHL). According to the company’s statement, it is personalized therapy for adult patients with relapsed or refractory B-NHL.